Want to see MED full AI Analyst Report?
Medifast (MED) Stock Statistics & Valuation Metrics
Total Valuation
Medifast has a market cap or net worth of $143.25M. The enterprise value is -$23.04M.
- Market Cap
- $143.25M
- Enterprise Value
- -$23.04M
Share Statistics
Medifast has 11,182,597 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 11,182,597
- Owned by Insiders
- 5.18%
- Owned by Institutions
- 29.67%
Financial Efficiency
Medifast’s return on equity (ROE) is -0.09 and return on invested capital (ROIC) is -6.50%.
- Return on Equity (ROE)
- -0.09
- Return on Assets (ROA)
- -0.07
- Return on Invested Capital (ROIC)
- -6.50%
- Return on Capital Employed (ROCE)
- -0.07
- Revenue Per Employee
- 1.02M
- Profits Per Employee
- -49.14K
- Employee Count
- 380
- Asset Turnover
- 1.50
- Inventory Turnover
- 5.47
Valuation Ratios
The current PE Ratio of Medifast is -3.62. Medifast’s PEG ratio is 0.00.
- PE Ratio
- -3.62
- PS Ratio
- 0.50
- PB Ratio
- 0.83
- Price to FCF
- -38.64
- Price to Operating Cash Flow
- -5749.61
- PEG Ratio
- 0.00
Income Statement
In the last 12 months, Medifast had revenue of 385.79M and earned -18.67M in profits. Earnings per share was -1.70.
- Revenue
- 385.79M
- Gross Profit
- 275.19M
- Operating Income
- -14.21M
- Pretax Income
- -5.64M
- Net Income
- -18.67M
- EBITDA
- 8.60M
- Earnings Per Share (EPS)
- -1.70
Cash Flow
In the last 12 months, operating cash flow was -26.00K and capital expenditures -3.84M, giving a free cash flow of -3.87M billion.
- Operating Cash Flow
- -26.00K
- Free Cash Flow
- -3.87M
- Free Cash Flow per Share
- -0.35
Dividends & Yields
Medifast pays an annual dividend of $1.65, resulting in a dividend yield of ―
- Dividend Per Share
- $1.65
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -2.60%
- Earnings Yield
- -27.41%
Stock Price Statistics
- Beta
- 1.14
- 52-Week Price Change
- 8.56%
- 50-Day Moving Average
- 12.06
- 200-Day Moving Average
- 11.33
- Relative Strength Index (RSI)
- 61.38
- Average Volume (3m)
- 121.97K
Important Dates
Medifast upcoming earnings date is Feb 23, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 26, 2026
- Next Earnings Date
- Feb 23, 2027
- Ex-Dividend Date
- Sep 18, 2023
Financial Position
Medifast as a current ratio of 4.69, with Debt / Equity ratio of 8.44%
- Current Ratio
- 4.69
- Quick Ratio
- 4.22
- Debt to Market Cap
- 0.09
- Net Debt to EBITDA
- -8.43
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Medifast has paid 13.03M in taxes.
- Income Tax
- 13.03M
- Effective Tax Rate
- -2.31
Enterprise Valuation
Medifast EV to EBITDA ratio is -5.94, with an EV/FCF ratio of -28.79.
- EV to Sales
- 0.37
- EV to EBITDA
- -5.94
- EV to Free Cash Flow
- -28.79
- EV to Operating Cash Flow
- -4283.73
Balance Sheet
Medifast has $172.53M in cash and marketable securities with $20.68M in debt, giving a net cash position of $151.85M billion.
- Cash & Marketable Securities
- $172.53M
- Total Debt
- $20.68M
- Net Cash
- $151.85M
- Net Cash Per Share
- $13.58
- Tangible Book Value Per Share
- $16.12
Margins
Gross margin is 69.21%, with operating margin of -10.88%, and net profit margin of -13.64%.
- Gross Margin
- 69.21%
- Operating Margin
- -10.88%
- Pretax Margin
- -9.73%
- Net Profit Margin
- -13.64%
- EBITDA Margin
- -6.26%
- EBIT Margin
- -9.73%
Analyst Forecast
The average price target for Medifast is $12.00, which is 11.43% higher than the current price. The consensus rating is Neutral
- Price Target
- $12.00
- Price Target Upside
- 6.32% Downside
- Analyst Consensus
- Neutral
- Analyst Count
- 1
- Revenue Growth Forecast
- -30.28%
- EPS Growth Forecast
- -16409.29%
Scores
- Smart Score
- 6
- AI Score
- 48
